Spirulina does not decrease muscle damage nor oxdidative stress in cycling athletes with adequate nutritional status

The objective of this study was to assess the effect of Spirulina maxima on oxidative stress and muscle damage in cycling athletes subjected to high volume and intensity of training. Eighteen male athletes were randomly divided into an experimental group (n=11) with age 27.8±3.5 and placebo (n=7) with age 34.3±2.3 in a double-blind fashion. They carried out a protocol of Spirulina dietary supplementation (7.5 g/day) of placebo for four weeks and maintained their trainings during this period. A nutritional anamnesis was performed and blood tests were done to determine pre and post levels of creatine kinase (CK), lactic dehydrogenase (LHD), superoxide dismutase (SOD) and malondialdehyde (MDA). The supplemented and placebo groups performed the same volume training, has adequate macronutrients and antioxidant vitamins ingestion before study, as well as initial CK, LDH, SOD and MDA levels. Supplementation did not promote a significant alteration in CK levels on supplemented group (158.4±16.3 for 140.0±16.6 U/l, p>0.05), LDH (420±13.2 for 394.9±27.9 UI/l, p>0.05), MDA (2.8±0.2 for 2.9±0.4 nmol/ml, p>0.05), nor an increase in the SOD (7.3±0.6 for 7.0±0.6 U/mg Hb, p>0.05). We conclude that administration of Spirulina does not interfere in the magnitude of muscle damage nor in antioxidant status of cycling athletes that practice intense training

Predictors of major complications after elective abdominal surgery in cancer patients

Background: Patients undergoing abdominal surgery for solid tumours frequently develop major postoperative complications, which negatively affect quality of life, costs of care and survival. Few studies have identified the determinants of perioperative complications in this group. Methods: We performed a prospective observational study including all patients (age>18) undergoing abdominal surgery for cancer at a single institution between June 2011 and August 2013. Patients undergoing emergency surgery, palliative procedures, or participating in other studies were excluded. Primary outcome was a composite of 30-day all-cause mortality and infectious, cardiovascular, respiratory, neurologic, renal and surgical complications. Univariate and multiple logistic regression analyses were performed to identify predictive factors for major perioperative adverse events. Results: Of a total 308 included patients, 106 (34.4%) developed a major complication during the 30-day follow-up period. Independent predictors of postoperative major complications were: age (odds ratio [OR] 1.03 [95% CI 1.01-1.06], p=0.012 per year), ASA (American Society of Anesthesiologists) physical status greater than or equal to 3 (OR 2.61 [95% CI 1.33-5.17], p=0.003), a preoperative haemoglobin level lower than 12g/dL (OR 2.13 [95% CI 1.21-4.07], p=0.014), intraoperative use of colloids (OR 1.89, [95% CI 1.03-4.07], p=0.047), total amount of intravenous fluids (OR 1.22 [95% CI 0.98-1.59], p=0.106 per litre), intraoperative blood losses greater than 500mL (2.07 [95% CI 1.00-4.31], p=0.043), and hypotension needing vasopressor support (OR 4.68 [95% CI 1.55-27.72], p=0.004). The model had good discrimination with the area under the ROC curve being 0.80 (95% CI 0.75-0.84, p<0.001). Conclusions: Our findings suggest that a perioperative strategy aimed at reducing perioperative complications in cancer surgery should include treatment of preoperative anaemia and an optimal fluid strategy, avoiding fluid overload and intraoperative use of colloids.SCOPUS: ar.jinfo:eu-repo/semantics/publishe